Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 8, 2009 - Issue 6
Submit an article Journal homepage
474
Views
42
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

A review of acitretin for the treatment of psoriasis

Chai Sue Lee
, MD MS &
Kai Li University of California Davis Medical Center, Department of Dermatology, 3301 C Street, Suite 1400, Sacramento, CA 95816, USA +1 916 734 6760+1 916 442 5702; [email protected]
Pages 769-779 | Published online: 06 Nov 2009

Bibliography

  • Drake LA, Ceilley RI, Cornelison RL, Guidelines of care for psoriasis. J Am Acad Dermatol 1993;28:632-7
  • Available from: http://psoriasis.org
  • Lebwohl M, Menter A, Koo J, Feldman SR. Case studies in severe psoriasis: a clinical strategy. J Dermatol Treat 2003;14(Suppl 2):26-46
  • Fowler JF, Duh MS, Rovba L, The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol 2008;59(5):772-80
  • Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44
  • Coven TR, Burack LH, Gillaeudeau P, Narrowband UVB produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UVB. Arch Dermatol 1997;133:1514-22
  • Karvonen J, Kokkonen EL, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol 1989;69:82-5
  • Picot E, Meunfer L, Picot-Debeze MC. Treatment of psoriasis with a 311 nm UVB lamp. Br J Dermatol 1992;127:509-12
  • Van Weelden H, De La Faille HB, Young E, Van Der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988;119:11-9
  • Van Weelden H, Van der Leun JC. Improving the effectiveness of phototherapy for psoriasis. Br J Dermatol 1984;111:484
  • Ibbotson SH, Bilsland D, Cox NH, An update and guidance on narrowband UVB phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004;151:283-97
  • Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Cancer 1994;73(11):2759-64
  • Stern RS, Liebman EJ, Vakeva L. PUVA follow-up study: oral psoralen and ultraviolet light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. J Natl Cancer Inst 1998;90(17):1278-84
  • Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-up Study. N Engl J Med 1997;336(15):1041-5
  • Murase JE, Lee EE, Koo J. Effect of ethnicity on the risk of developing nonmelanoma skin cancers following long-term PUVA therapy. Int J Dermatol 2005;44(12):1016-21
  • Kreuger G. Current concepts and review of alefacept in the treatment of psoriasis. Dermatol Clin 2004;22:407-26
  • Leonardi CL, Kimball AB, Papp KA, Efficacy and safety of ustekinumab, a human interleukin- 12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHEONIX 1). Lancet 2008;371:1665-74
  • Papp KA, Langley RG, Lebwohl M, Efficacy and safety of ustekinumab, a human interleukin- 12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 2008;371:1675-84
  • Weinstein GD, White WG. An approach to the treatment of moderate to severe psoriasis with rotational therapy. J Am Acad Dermatol 1993;28(3):454-9
  • Lebwohl M. Moderate-to-Severe Psoriasis. New York: Informa Healthcare, 2009
  • Wiegand UW, Chou RC. Pharmacokinetics of acitretin and etretinate. J Am Acad Dermatol 1998;39(2 Pt 3):S25-33
  • Larsen FG, Jakobsen P, Knudsen J, Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol 1993;100:623-7
  • Laugier JP, De Sousa G, Bun H, Acitretin biotransformation into etretinate: role of ethanol on in vitro hepatic metabolism. Dermatology 1994;188:122-5
  • Pearce DJ, Nelson AA, Fleischer AB, The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies. J Dermatol Treat 2006;17:29-37
  • Chambon P. The retinoid signaling pathway: molecular and genetic analysis. Semin Cell Biol 1994;5:115-25
  • Saurat JH. Retinoids: 10 Years On/Retinoid Symposium. Switzerland: S Karger Pub, 1991
  • Weinstein GD, Gottlieb AB. Therapy of Moderate-to-Severe Psoriasis. New York: Marcel Dekker, 2003.
  • McClure SL, Valentine J, Gordon KB. Comparative tolerability of systemic treatments9for plaque-type psoriasis. Drug Saf 2002;25:913-27
  • Brindley C. An overview of recent clinical pharmacokinetic studies with acitretin (Ro-167, etretin). Dermatologica 1989;178(2):79-87
  • Di Giovanna JJ, Zech LA, Ruddel ME, Etretinate. Persistent serum levels after long-term therapy. Arch Dermatol 1989;125(2):246-51
  • Geiger JM, Saurat JH. Acitretin and etretinate. How and when they should be used. Dermatol Clin 1993;11:117-29
  • McNamara PJ, Jewell RC, Jensen BK, Brindley CJ. Food increases the bioavailability of acitretin. J Clin Pharmacol 1988;28:1051-5
  • Geiger JM, Czarnetzki BM. Acitretin (Ro 10-167, etretin): overall evaluation of clinical studies. Dermatologica 1988;176:182-90
  • Goldfarb MT, Ellis CN, Gupta AK, Acitretin improved psoriasis in a dose-dependent fashion. J Am Acad Dermatol 1988;18:655-62
  • Lassus A, Geiger JM, Nyblom M, Treatment of severe psoriasis with etretin (Ro 10-1670). Br J Dermatol 1987;117:333-41
  • Ling M. Acitretin: optimal dosing strategies. J Am Acad Dermatol 1999;41(3):S2-6
  • Lowe NJ, Lazarus V, Matt L. Systemic retinoid therapy for psoriasis. J Am Acad Dermatol 1988;19:186-91
  • Murray HE, Anhalt AW, Lessard R, A 12 month treatment of severe psoriasis with acitretin: results of a Canadian open multicenter trial. J Am Acad Dermatol 1991;24:598-602
  • Olsen EA, Weed WW, Meyer CJ, Cobo LM. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis. J Am Acad Dermatol 1989;21:681-6
  • Torol L, Kadar L, Geiger JM. Acitretin treatment of severe psoriasis. Acta Derm Venereol Suppl 1989;146:104-6
  • Efficacy and safety of low-dose acitretin for the treatment of moderate to severe plaque-type psoriasis: Presented at AAD Doctor's Guide to Medical and Other News. San Francisco, CA: P\S\L Consulting Group Inc., 2006. Available from: http://www.docguide.com/dg.nsf/PrintPrint/9396D69218FAA7C78525712A0058A704. [Last accessed 4 October 2009]
  • Ozawa A, Ohkido M, Haruki Y, Treatment of generalized pustular psoriasis: a multicenter study in Japan. J Dermatol 1999;26:141-9
  • Koo J. Sequential therapy of psoriasis. Introducing a new therapeutic paradigm for better clinical results. J Am Acad Dermatol 1999;41:S25-8
  • Pilkington T, Brogden RN. Acitretin: a review of its pharmacology and therapeutic use. Drugs 1992;43(4): p. 597-627
  • Giannetti A, Coppini M, Gertazonni MG, Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis. J Eur Acad Dermatol Venerol 1999;13:91-5
  • Rim JH, Park JY, Choe YB, Youn JI. The efficacy of calcipotriol and acitretin combination therapy for psoriasis. Am J Clin Dermatol 2003;4(7):507-10
  • Van De Kerkhof PC, Cambazard F, Hutchinson PE, The effect of addition of calcipotriol ointment to acitretin therapy in psoriasis. Br J Dermatol 1998;138:84-9
  • Laurahanta J, Geiger JM. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. Br J Dermatol 1989;121:107-12
  • Saurat J, Geiger JM, Amblard P, Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA, and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988;177:218-24
  • Tanew A, Guggenbichler A, Honigsmann H, Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J Am Acad Dermatol 1991;26:682-4
  • Lindelof B, Sigurgeirsson B, Tegner E, PUVA and cancer: a large-scale epidemiologic study. Lancet 1991;338:91-3
  • Van de Kerkhof PCM, de Rooij MJM. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance. Br J Dermatol 1997;136:275-8
  • Nijsten TE, Stern RS. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J Am Acad Dermatol 2003;49(4):644-50
  • Bavinck JN, Tieben LM, Van der Woulde FJ, Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995;13(8):1933-8
  • Conley J, Nanton J, Dhawan S, Novel combination regimens: Biologics and acitretin for the treatment of psoriasis - a case series. J Dermatol Treat 2006;17:86-9
  • Iyer S, Yamauchi P, Lowe NJ. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy. Br J Dermatol 2002;146:118-21
  • Otley CC, Stasko T, Tope WD, Chemoprevention of nonmelanoma skin cancer with systemic retinoids: Practical dosing and management of adverse effects. Dermatol Surg 2006;32:562-8
  • Hannuksela-Svahn A, Sigurgeirrson B, Pukkala E, Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 1999;141:497-501
  • Muchenberger S, Schopf E, Simon JC. The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis. Br J Dermatol 1997;137:587-9
  • Iest J, Boer J. Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone. Br J Dermatol 1989;120:665-70
  • Lebwohl M. Acitretin in combination with UVB or PUVA. J Am Acad Dermatol 1999;41(3 Pt 2):S22-4
  • Lowe N, Prystowsky JH, Bourget T, Acitretin plus UVB therapy for psoriasis: comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol 1991;24:591-4
  • Ruzicka T, Sommerburg C, Braun-Falco O, Efficacy of acitretin in combination with UV-B in the treatment of severe psoriasis. Arch Dermatol 1990;126:482-6
  • Spuls PI, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. J Dermatol Treat 2003;14(Suppl 2):17-20
  • Stiefel Laboratories, Soriatane (acitretin) prescribing information. Stiefel Laboratories, Inc., Coral Gables, FL; USA;2007
  • Lowenthal KE, Horn PJ, Kalb RE. Concurrent use of methotrexate and acitretin revisited. J Dermatol Treat 2008;19:22-6
  • Gisondi P, Del Giglio M, Cotena C, Girolomoni G. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 2008;158:1345-9
  • Stiefel Research Institute. Data on file
  • David M, Hodak E, Lowe NG. Adverse effects of retinoids. Med. Toxicol 1988;3:273-88
  • Rowe A. Retinoids X receptors. Int J Biochem Cell Biol 1997;29:276-8
  • Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol 2001;45:649-61
  • Fraunfelder FW, Fraunfelder FT. Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension. J Neuro opthalmol 2004;24(3):214-16
  • Stuart BH, Litt IF. Tetracycline-associated intracranial hypertension in an adolescent: A complication of systemic acne therapy. J Pediatr 1978;92:679-80
  • Walters BN, Gubbay SS. Tetracycline and benign intracranial hypertension: Report of 5 cases. Br J Dermatol 1981;282:19-20
  • Katz HI, Waalen J, Leach EE. Acitretin in psoriasis: an overview of adverse effects. J Am Acad Dermatol 1999;41(3 Pt 2):S7-12
  • Lee E, Koo J. Single-center retrospective study of long-term use of low-dose acitretin (soriatane) for psoriasis. J Dermatol Treat 2004;15:8-13
  • Gilbert M, Ellis CN, Voorhees JJ. Lack of skeletal radiographic changes during short-term etretinate therapy in children. Dermatologica 1986;172:160-3
  • Prendiville J, Bingham EA, Burrows D. Premature epiphyseal closeure - a complication of etretinate therapy in children. J Am Acad Dermatol 1986;15(6):1259-62
  • Roenigk HH Jr, Callen J, Guzzo CA, Effects of acitretin on the liver. Obstet Gynecol 1999;41:584-8
  • Leithead JA, Simpson KJ, MacGilchrist AJ. Fulminant hepatic failure following overdose of the vitamin A metabolite actiretin. J of Gastroenterol Hepatol 2009;21:230-2
  • Stern RS, Fitzgerald E, Ellis CN, The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study. J Am Acad Dermatol 1995;33:44-52
  • Otley CC, Stasko T, Tope WD, Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 2006;32:562-8
  • Bavinck JN, Tieben LM, Van der Woude FJ, Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995;13(8):1933-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.